chr19-29527373-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001146339.2(VSTM2B):​c.245G>A​(p.Ser82Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000266 in 1,541,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

VSTM2B
NM_001146339.2 missense

Scores

10
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.41

Publications

0 publications found
Variant links:
Genes affected
VSTM2B (HGNC:33595): (V-set and transmembrane domain containing 2B) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
VSTM2B-DT (HGNC:27615): (VSTM2B divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07738033).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSTM2BNM_001146339.2 linkc.245G>A p.Ser82Asn missense_variant Exon 2 of 5 ENST00000335523.8 NP_001139811.1 A6NLU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSTM2BENST00000335523.8 linkc.245G>A p.Ser82Asn missense_variant Exon 2 of 5 5 NM_001146339.2 ENSP00000335038.6 A6NLU5
VSTM2B-DTENST00000804084.1 linkn.116+1668C>T intron_variant Intron 1 of 4
VSTM2B-DTENST00000804085.1 linkn.116+1668C>T intron_variant Intron 1 of 3
VSTM2B-DTENST00000804102.1 linkn.103+1339C>T intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000113
AC:
16
AN:
141078
AF XY:
0.000105
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00160
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000238
AC:
33
AN:
1388786
Hom.:
0
Cov.:
33
AF XY:
0.0000219
AC XY:
15
AN XY:
685064
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30672
American (AMR)
AF:
0.00
AC:
0
AN:
35264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24938
East Asian (EAS)
AF:
0.000767
AC:
27
AN:
35210
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44930
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5628
European-Non Finnish (NFE)
AF:
9.29e-7
AC:
1
AN:
1076226
Other (OTH)
AF:
0.0000867
AC:
5
AN:
57688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152260
Hom.:
0
Cov.:
33
AF XY:
0.0000806
AC XY:
6
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41570
American (AMR)
AF:
0.00
AC:
0
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00156
AC:
8
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 27, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.245G>A (p.S82N) alteration is located in exon 2 (coding exon 2) of the VSTM2B gene. This alteration results from a G to A substitution at nucleotide position 245, causing the serine (S) at amino acid position 82 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.010
T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.68
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.077
T
MetaSVM
Uncertain
0.32
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
5.4
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.51
Sift
Benign
0.031
D
Sift4G
Uncertain
0.057
T
Polyphen
1.0
D
Vest4
0.36
MutPred
0.45
Gain of catalytic residue at S82 (P = 0.0203);
MVP
0.47
ClinPred
0.15
T
GERP RS
4.5
Varity_R
0.31
gMVP
0.54
Mutation Taster
=39/61
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540696299; hg19: chr19-30018280; API